Compare Charles River Laboratories Intl. Inc (CRL) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Consumer Staples Select Sector SPDR Fund — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Consumer Staples Select Sector SPDR Fund trades at $83.43 (market cap $13.50B). The key difference: Charles River Laboratories Intl. Inc and Consumer Staples Select Sector SPDR Fund are close in size by market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Consumer Staples Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Consumer Staples Select Sector SPDR Fund for 72 Days on average.
| CRL | XLP | |
|---|---|---|
Market Cap | $14.23B | $13.50B |
Volume | 1,176,885 | 14,599,953 |
Sector | Health | — |
52-Week High | $310.77 | $90.00 |
52-Week Low | $149.93 | $75.61 |
Typical Hold Time | 33 Days | 72 Days |
Enterprise Value | $17.06B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298, down 0.77% on the day, with strong analyst support showing 73% buy ratings and a $305.50 consensus price target. The stock maintains a bullish technical outlook with support at $292 and resistance at $301, while recent earnings have consistently beaten expectations despite negative net income margins. The company's 2026 Investor Day highlighted a strategic vision targeting 5-7% organic growth and $300 million in savings by 2030.
CRL presents a compelling growth story with solid operational cash flow and strategic initiatives, though investors face risks from negative profitability metrics and elevated valuation multiples. The stock's current position near analyst targets suggests limited upside without improved earnings execution, while ongoing margin pressures and debt levels require careful monitoring amid the company's transformation efforts.
XLP (Consumer Staples Select Sector SPDR ETF) trades at $83.42, up 2.11% with a bullish technical signal supported by moving averages and oscillators. The ETF shows strong defensive characteristics amid market volatility, with 100% analyst buy ratings and a forthcoming dividend. Recent news highlights its outperformance versus discretionary sectors and competitive positioning against peers like VDC and IYK.
Outlook remains positive given defensive sector strength and favorable expense ratio, though risks include interest rate sensitivity and consumer spending shifts. The ETF's focus on household staples provides stability, but elevated RSI levels suggest near-term consolidation potential before further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
